Document:

Exhibit 4.1

 

Form of

 

COMMON STOCK PURCHASE WARRANT

 

JR RESOURCES CORP.

 

	Warrant
    Shares: ______________	Issue Date:
    [___], 2022
	 	Initial
    Exercise Date: [___], 2022

 

CUSIP:
[_____]

ISIN: [____]

 

THIS
COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, CEDE & CO. or its
registered assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00
p.m. (New York City time) on March 15, 2026 (the "Termination Date") but not thereafter, to subscribe for
and purchase from JR Resources Corp., a Nevada corporation (the "Company"), up to _________________ shares of
Common Stock (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one share of Common Stock
under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and
maintained in the form of a security held in book-entry form and The Depository Trust Company or its nominee ("DTC")
shall initially be the sole registered holder of this Warrant, subject to a Holder's right to elect to receive a Warrant in certificated
form pursuant to the terms of the Warrant Agent Agreement, in which case this sentence shall not apply.

 

Section 1.         Definitions.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:

 

"Affiliate"
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

"Bid
Price" means, for any date, the price determined by the first of the following clauses that applies: (a) if the
Common Stock is then listed or quoted on a Trading Market, the bid price of a share of Common Stock for the time in question (or the
nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not
a Trading Market, the volume weighted average per share price of the Common Stock for such date (or the nearest preceding date) on OTCQB
or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the
Common Stock are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting
prices), the most recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a
share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the
Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

     

     

    

 

"Board
of Directors" means the board of directors of the Company.

 

"Business
Day" means any day other than Saturday, Sunday or other day on which banks in Reno, Nevada; Lead, South Dakota; or New
York, New York are authorized or required by applicable law to be closed.

 

"Commission"
means the United States Securities and Exchange Commission.

 

"Common
Stock" means the common stock, par value $0.001 per share, of the Company, and any other class of securities into which
such securities may hereafter be reclassified or changed.

 

"Common
Stock Equivalents" means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.

 

"Exchange
Act" means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

"Person"
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

"Registration
Statement" means the Company's registration statement on Form S-1 (File No. 333- [ __ ]).

 

"Securities
Act" means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

"Subsidiary"
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company
formed or acquired after the date hereof.

 

"Trading
Day" means a day on which the Common Stock is traded on a Trading Market.

 

"Trading
Market" means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New
York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).

 

"Transfer
Agent" means Odyssey Trust Company, a trust company incorporated under the laws of Alberta as the transfer agent of the
Common Stock, with a mailing address of 323-409 Granville Street, Vancouver, BC V6C 1T2 and any successor transfer agent of the Common
Stock.

 

"VWAP"
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is
then listed or quoted on a Trading Market, the daily volume weighted average price per share of the Common Stock for such date (or the
nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not
a Trading Market, the volume weighted average price per share of the Common Stock for such date (or the nearest preceding date) on OTCQB
or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the
Common Stock are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting
prices), the most recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a
share of Common Stock as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the
Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

     

     

    

 

"Warrant
Agent Agreement" means that certain warrant agent agreement, dated on or about the Initial Exercise Date, between the
Company and the Warrant Agent.

 

"Warrant
Agent" means, Odyssey Trust Company and any successor warrant agent of the Company.

 

"Warrants"
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.

 

Section 2.         Exercise.

 

(a)          Exercise
of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or
after the Initial Exercise Date and on or before the Termination Date, by delivery to the Warrant Agent (with a copy to the Company)
of a duly executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed
hereto as Annex A (the "Notice of Exercise"), and delivery of the aggregate Exercise Price of the Warrant Shares specified
in the applicable Notice of Exercise as specified in this Section 2(a). Within the earlier of (i) two (2) Trading Days
and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(c)(i) herein) following
the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable
Notice of Exercise by wire transfer of immediately available funds or cashier's check drawn on a United States bank. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Warrant Agent until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Warrant Agent for cancellation within three (3) Trading Days
of the date on which the final Notice of Exercise is delivered to the Warrant Agent. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. The Holder and any assignee, by acceptance of
this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.

 

     

     

    

 

 

Notwithstanding the foregoing
in this Section 2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this
Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect
exercises made pursuant to this Section 2(a) by delivering to DTC (or such other clearing corporation, as applicable) the appropriate
instruction form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation,
as applicable), subject to a Holder's right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agent
Agreement, in which case this sentence shall not apply.

 

(b)          Exercise
Price. The exercise price per share of Common Stock under this Warrant shall be $2.08 subject to adjustment hereunder (the "Exercise
Price").

 

(c)          Mechanics
of Exercise.

 

(i)           Delivery
of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder's or its designee's balance account with The Depository Trust Company through
its Deposit or Withdrawal at Custodian system ("DWAC") if the Company is then a participant in such system and there
is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder, and
otherwise by physical delivery of a certificate, registered in the Company's share register in the name of the Holder or its designee,
for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in
the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the
Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the
number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date,
the "Warrant Share Delivery Date"). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate
purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective
of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price is received within the earlier of
(i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery
of the Notice of Exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this
Warrant remains outstanding and exercisable. As used herein, "Standard Settlement Period" means the standard settlement
period, expressed in a number of Trading Days, on the Company's primary Trading Market with respect to the Common Stock as in effect
on the date of delivery of the Notice of Exercise.

 

(ii)          Delivery
of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.

 

     

     

    

 

(iii)          Rescission
Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(c)(i) by
the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; provided, however, that the Holder shall
be required to return any Warrant Shares subject to any such rescinded exercise notice concurrently with the return to Holder of the
aggregate Exercise Price paid to the Company for such Warrant Shares and the restoration of Holder's right to acquire such Warrant Shares
pursuant to this Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).

 

(iv)          No
Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.

 

(v)          Charges,
Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided,
however, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto as Annex B duly executed by the Holder and
the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.
The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of
the Warrant Shares.

 

(vi)         Closing
of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.

 

Section 3.         Certain
Adjustments.

 

(a)          Stock
Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of
shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a
fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately
before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event,
and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price
of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification.

 

     

     

    

 

(b)          Pro
Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to all (or substantially all) of holders of shares of Common Stock, by way of return
of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way
of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a "Distribution"),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant immediately before the date of which a record is taken for such Distribution, or, if no such record
is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution.

 

(c)          Fundamental
Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions
consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than
50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making
or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business
combination) (each a "Fundamental Transaction"), then, upon any subsequent exercise of this Warrant, the Holder shall
have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence
of such Fundamental Transaction, at the option of the Holder, the number of shares of Common Stock of the successor or acquiring corporation
or of the Company, if it is the surviving corporation, and any additional consideration (the "Alternate Consideration")
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction. For purposes of any such exercise, the determination of the Exercise Price
shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect
of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders
of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder
shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental
Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the
 "Successor Entity") to assume in writing all of the obligations of the Company under this Warrant in accordance with
the provisions of this Section 3(c) pursuant to written agreements in form and substance reasonably satisfactory to the Holder
and the Warrant Agent and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the
option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock
of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this
Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise
price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares
of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital
stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation
of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any
such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such
Fundamental Transaction, the provisions of this Warrant referring to the "Company" shall refer instead to the Successor
Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant
with the same effect as if such Successor Entity had been named as the Company herein.

 

     

     

    

 

(d)          Calculations.
All calculations under this Section 3 shall be made by the Company to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given
date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

(e)          Notice
to Holder.

 

(i)           Adjustment
to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Warrant Agent pursuant to Section 4 of the Warrant Agent Agreement and to the Holder by facsimile or email a notice
setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth
a brief statement of the facts requiring such adjustment.

 

     

     

    

 

(ii)          Notice
to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party,
any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted
into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the
Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar
days prior to the applicable record or effective date hereinafter specified, a notice (unless such information is filed with the Commission,
in which case a notice shall not be required) stating (x) the date on which a record is to be taken for the purpose of such dividend,
distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock
of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their Common Stock for securities,
cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that
the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action
required to be specified in such notice. The Holder shall remain entitled to exercise this Warrant during the period commencing on the
date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

(f)          Voluntary
Adjustment By Company. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term
of this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise Price to any amount and for any
period of time deemed appropriate by the Board of Directors.

 

Section 4.         Transfer
of Warrant.

 

(a)          Transferability.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of
this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay
any transfer taxes payable upon the making of such transfer accompanied by a signature guarantee from an "eligible guarantor institution"
that is a member or participant in the Securities Transfer Agents Medallion Program or other instrument satisfactory to the Warrant Agent.
Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall
issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three
(3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The
Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having
a new Warrant issued.

 

     

     

    

 

(b)          New
Warrants. If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be divided or combined
with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names
and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a),
as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants
in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or
exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of
Warrant Shares issuable pursuant thereto.

 

(c)          Warrant
Register. The Warrant Agent shall register this Warrant, upon records to be maintained by the Warrant Agent for that purpose (the
 "Warrant Register"), in the name of the record Holder hereof from time to time. The Company and the Warrant Agent may
deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.

 

Section 5.         Miscellaneous.

 

(a)          No
Rights as Stockholder until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(c)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive cash payments pursuant to Section 2(c)(i) herein,
including if the Company is for any reason unable to issue and deliver Warrant Shares upon exercise of this Warrant as required pursuant
to the terms hereof, in no event shall the Company be required to net cash settle an exercise of this Warrant or cash settle in any other
form.

 

(b)          Loss,
Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of any Warrant held in book-entry
from through DTC, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate,
if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in
lieu of such Warrant or stock certificate.

 

(c)          Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.

 

     

     

    

 

(d)          Authorized
Shares.

 

The Company covenants that,
during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares
to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants
that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary
Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be
necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).

 

Except and to the extent
as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately
prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may
validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before taking any action
which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the
Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.

 

     

     

    

 

(e)          Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys' fees and
other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. Notwithstanding the
foregoing, nothing in this paragraph shall limit or restrict the federal district court in which a Holder may bring a claim under the
U.S. federal securities laws.

 

(f)          Restrictions.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions
upon resale imposed by state and federal securities laws.

 

(g)          Non-waiver
and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder's rights, powers or remedies. No provision of this Warrant shall be construed
as a waiver by the Holder of any rights which the Holder may have under the U.S. federal securities laws and the rules and regulations
of the Commission thereunder. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply
with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts
as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys' fees, including those of
appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights,
powers or remedies hereunder.

 

(h)          Notices.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any
Notice of Exercise, shall be in writing and delivered personally, or sent by a nationally recognized overnight courier service, first-class
mail, postage prepaid, addressed to the Warrant Agent, at 323-409 Granville Street, Vancouver, BC V6C 1T2, Attention: President, or such
other address as the Warrant Agent may specify for such purposes by notice to the Holders. Any and all notices or other communications
or deliveries to be provided to the Company shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally
recognized overnight courier service, addressed to the Company, at 1588-609 Granville Street, Vancouver, BC, V7Y 1H4, Attention:
Chief Executive Officer, or such other facsimile number, email address or address as the Company may specify for such purposes by notice
to the Warrant Agent and the Holders. Any and all notices or other communications or deliveries to be provided to the Holders hereunder
shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier service addressed
to each Holder at the facsimile number, e-mail address or address of such Holder appearing on the books of the Company or the Warrant
Agent. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the
time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or via e-mail at the e-mail
address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after
the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or via e-mail at the e-mail
address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading
Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service,
or (iv) upon actual receipt by the party to whom such notice is required to be given.

 

     

     

    

 

(i)          Limitation
of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any share of Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors
of the Company.

 

(j)          Remedies.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.

 

(k)          Successors
and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.

 

(l)          Amendment.
This Warrant may be modified or amended or the provisions hereof waived in accordance with 7.12(c) of the Warrant Agent Agreement.

 

(m)          Severability.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

(n)          Headings.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.

 

(o)          Warrant
Agent Agreement. If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is issued subject
to the Warrant Agent Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant Agent
Agreement, the provisions of this Warrant shall govern and be controlling with respect to the rights and obligations of the Holders and
the Company, provided that, with respect to the rights, duties, obligations, protections, immunities and liability of the Warrant Agent,
the Warrant Agent Agreement shall govern and control.

 

     

     

    

 

********************

 

(Signature Page Follows)

 

     

     

    

 

IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

	JR
RESOURCES CORP.
	 	 
	By:
	 	 
	Name:	 	 
	Title:	 	 

 

Countersigned:

 

ODYSSEY
TRUST COMPANY, as Warrant Agent

 

	By:
    	 	 
	Name:	 	 
	Title:
	

     
	 

 

     

     

    

 

ANNEX A

 

NOTICE OF EXERCISE

 

	To:	JR
    Resources corp.

 

(1)          The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2)          Payment
shall take the form of lawful money of the United States.

 

(3)          Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

		 	 
	 	 	 

The Warrant Shares shall be delivered to the
following DWAC Account Number:

		 	 

		 	 

		 	 

 

[SIGNATURE OF HOLDER]

 

Name of Investing Entity:

		 	 

Signature
of Authorized Signatory of Investing Entity:

		 	 

Name of Authorized Signatory:

		 	 

Title of Authorized Signatory:

		 	 

Date:

		 	 

 

     

     

    

 

ANNEX B

 

ASSIGNMENT FORM

 

(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to:

 

	Name:	 
	 	(Please
    Print)
	Address:	 
	 	(Please
    Print)
	Phone
    Number:	 
	Email
    Address:	 
	Dated:
    _______________ __, ______	 
	Holder's
    Signature:	 	 
	Holder's
    Address:	 	 
	(Signature
    Guaranteed):	Date:
                                   ,                    	
	 	 	 	 

 

Signature to be guaranteed by an "eligible
guarantor institution" that is a member or participant in the Securities Transfer Agents Medallion Program.ex_347535.htm

EXHIBIT 4.2

 

DESCRIPTION OF REGISTRANT’S SECURITIES

REGISTERED PURSUANT TO SECTION 12

OF THE SECURITIES EXCHANGE ACT OF 1934

 

(Exhibit pursuant to Item 601(b)(4)(vi) of Regulation S-K)

 

General

 

Enterprise Diversified, Inc., a Nevada corporation (the “Company,” “we,” “us” or “our”), has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our Common Stock (as defined below), registered pursuant to Section 12(g) of the Exchange Act.

 

The following description briefly summarizes information about our capital stock, including our Common Stock. This information does not purport to be complete, and is subject to and qualified in its entirety by reference to (i) the Company’s articles of incorporation, as amended (as so amended, our “Articles of Incorporation”), and (ii) the Company’s bylaws, as amended (as so amended, our “Bylaws”), copies of each of which are filed and incorporated by reference as exhibits to the Annual Report on Form 10-K of which this Exhibit is a part. We encourage you to read our Articles of Incorporation, our Bylaws and the relevant provisions of Chapter 78 of Nevada Revised Statutes – the general corporation law of the state in which we are incorporated – for additional information.

 

Authorized Capital Stock

 

Our Articles of Incorporation authorize an aggregate of 40,000,000 shares of capital stock of the Company, consisting of (i) 10,000,000 authorized shares of common stock, par value $0.125 per share (“Common Stock”), and (ii) 30,000,000 authorized shares of serial preferred stock, par value $0.001 per share (“Preferred Stock”).

 

As of March 25, 2022, there were 2,647,383 shares of our Common Stock issued and outstanding. To date, the Company has not issued any shares of Preferred Stock.

 

Common Stock

 

General

 

Each share of Common Stock has the same relative rights as, and is identical in all respects to, each other share of Common Stock.

 

Voting Rights

 

Each share of Common Stock entitles the holder thereof to one (1) vote on all matters to be voted upon by stockholders. There are no cumulative voting rights. Members of our Board of Directors are elected by a majority of the votes cast at a meeting of stockholders, by the holders of shares of stock present in person or by proxy, entitled to vote.

 

Dividend Rights

 

Subject to any preferential rights of any series of Preferred Stock, holders of shares of our Common Stock are entitled to share ratably in dividends, if any, when and as may be declared by our Board of Directors out of funds legally available therefor. The declaration and payment of any cash dividends on our Common Stock is solely within the discretion of our Board of Directors, and is dependent on our earnings and financial condition and any other factors as our Board of Directors considers relevant. We have not paid cash dividends on shares of our Common Stock to date.

 

Liquidation Rights

 

In the event of the Company’s liquidation, dissolution or winding-up, whether voluntary or involuntary, after payment or provision for payment of the debts and other liabilities of the Company and any amounts to which holders of Preferred Stock may be entitled, holders of shares of our Common Stock are entitled to share ratably in the Company’s remaining assets, if any.

 

No Preemptive or Conversion Rights

 

Holders of shares of our Common Stock do not have any preemptive rights to purchase additional shares of Common Stock, nor are there any conversion or redemption rights associated with shares of our Common Stock.

 

Other Matters

 

Our Common Stock is not subject to further calls or assessments by the Company, and there are no redemption or sinking fund provisions applicable to our Common Stock.

 

The rights, preferences and privileges of holders of our Common Stock may be subject to and be adversely affected by the rights of holders of shares of any series of Preferred Stock that we may designate and issue in the future.

 

Listing

 

Shares of our Common Stock currently trade on the OTC QB Market (OTCQB) under the symbol “SYTE”.

 

Transfer Agent

 

Colonial Stock Transfer Company, Inc., 66 Exchange Place, Suite 100, Salt Lake City, Utah 84111, is the transfer agent and registrar for our Common Stock.

 

 

 

 

Preferred Stock

 

The Company’s Board of Directors is authorized to provide from time to time for the issuance of shares of Preferred Stock in one or more series, and to fix and determine the designation and relative rights and preferences of each series of Preferred Stock, and the restrictions or qualifications thereof.

 

On July 29, 2020, the Company filed a Certificate of Designation, designating the first series of our Preferred Stock as the Series A Preferred Stock, consisting of 250,000 shares so designated (the “Series A Preferred Stock”). A copy of such Certificate of Designation is filed and incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit is a part, and we encourage you to read it for a complete description of the terms of the Series A Preferred Stock.

 

In the event of our issuance of any shares of the Series A Preferred Stock, the holders thereof would have certain rights, preferences and privileges ranking prior and superior to the rights of holders of our Common Stock. Such rights, preferences and privileges include, for example:

 

	 	
			●

				
			Holders of shares of the Series A Preferred Stock, in preference to the holders of our Common Stock, would be entitled to receive quarterly cash dividends in an amount per share equal to the greater of (i) $50 and (ii) 100 times the aggregate per share amount of all cash dividends declared on our Common Stock during the period.

			

 

	 	
			●

				
			Furthermore, until accrued and unpaid dividends and distributions, whether or not declared, on the outstanding shares of the Series A Preferred Stock have been paid in full, the Company would be prohibited from declaring or paying dividends, or making any other distributions, on any shares of stock ranking junior, including the shares of our Common Stock.

			

 

	 	
			●

				
			Similarly, holders of shares of the Series A Preferred Stock would be entitled to receive certain preferential amounts upon any liquidation, dissolution or winding up of the Company; and, furthermore, in the event of any consolidation, merger, combination or similar Company transaction, holders of shares of the Series A Preferred Stock would be entitled to an amount per share equal to 100 times the aggregate amount of stock, securities and/or cash, as the case may be, into which or for which each share of our Common Stock is converted or exchanged in connection with such transaction.

			

 

	 	
			●

				
			Also, except as otherwise required by law, each share of the Series A Preferred Stock would entitle the holder thereof to 100 votes on all matters upon which holders of our Common Stock are entitled to vote, including the election of directors, and all other matters as required by law.

			

 

 

 

 

Certain Anti-Takeover Effects

 

Certain provisions of our Articles of Incorporation and our Bylaws, as well as certain provisions of Chapter 78 of Nevada Revised Statutes, may be deemed to have an anti-takeover effect and could operate to delay, defer, discourage or prevent takeover attempts or other changes in control of the Company which have not been approved by the Board of Directors (including takeovers which certain stockholders might deem to be favorable). For example, the following provisions and arrangements, in particular, may operate to render more difficult or discourage an unsolicited takeover attempt or acquisition, an assumption of control through acquisition of a large block of our Common Stock, a change in our incumbent management, or a similar change in control of the Company:

 

Special Meetings. Under our Bylaws, a special meeting of stockholders may be called only by our entire Board of Directors, any two Directors or our President. In addition, our Bylaws generally restrict the conduct of business at a special meeting other than as specified in the notice for such meeting. These provisions may impede or preclude a stockholder, as well as any third party, from bringing a matter before a special meeting of stockholders.

 

No Cumulative Voting. As noted above, our Articles of Incorporation do not permit stockholders any right to cumulative voting in the election of our Directors. The absence of cumulative voting may make it more difficult for a minority stockholder to secure Board representation or replace our Board of Directors or for a third party to obtain control of us by replacing our Board of Directors.

 

Authorized But Unissued Shares. Our authorized but unissued shares of Common Stock and Preferred Stock are available for future issuance by our Board of Directors without stockholder approval. The existence of authorized but unissued shares of Common Stock and Preferred Stock could discourage, or be used to defer or render more difficult, an attempt to obtain control of the Company by means of a proxy contest, tender offer, merger or otherwise.

 

Undesignated Preferred Stock. As noted above, under our Articles of Incorporation, our Board of Directors is authorized to create and issue from time to time, without stockholder approval, up to an aggregate of 30,000,000 shares of Preferred Stock in one or more series, and to establish the number of shares of any series of Preferred Stock and fix the designations, powers, preferences and rights of the shares of each series. Accordingly, our Board of Directors, without stockholder approval, may authorize the issuance of one or more series of Preferred Stock with voting and conversion rights that could proportionately reduce, minimize or otherwise adversely affect the voting power of holders of Common Stock and, accordingly under certain circumstances, could have the effect of delaying, deferring or preventing an attempt by others to gain control of the Company.

 

Series A Preferred Stock; Rights Agreement. As previously reported in our Current Report on Form 8-K filed on July 29, 2020, our Board of Directors approved and adopted a certain stockholder rights agreement styled as the Tax Benefit Preservation Plan, dated as of July 24, 2020 (the “Rights Agreement”), by and between the Company and Colonial Stock Transfer Company, Inc., as rights agent. The summary description of the material terms and conditions of the Rights Agreement and other information included in Item 1.01 of the aforementioned Current Report on Form 8-K is incorporated herein by reference. A copy of the Rights Agreement is also filed and incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit is a part, and we encourage you to read it for a complete description of its terms. Generally, the Rights Agreement provides for the issuance to our existing holders of Common Stock of certain rights which may be exercised to acquire shares (or fractions thereof) of the Series A Preferred Stock in the event that any person or group acquires beneficial ownership of 4.99% or more of our issued and outstanding Common Stock without the approval of our Board of Directors. As noted above, holders of shares of the Series A Preferred Stock are entitled to, among other rights and preferences, 100 votes per share on all matters submitted to a vote by stockholders of our Common Stock, including the election of directors, and all other matters as required by law. Accordingly, the Rights Agreement generally operates to cause substantial dilution to any person or group that acquires beneficial ownership of 4.99% or more of our issued and outstanding Common Stock without the approval of our Board of Directors. As a result, the overall effect of the Rights Agreement, including the issuance of rights thereunder and issuance of shares of the Series A Preferred Stock upon any exercise of such rights, likely may render more difficult or discourage any merger, tender or exchange offer or other business combination or significant share acquisition involving the Company that is not approved by our Board of Directors.

 

Nevada Anti-Takeover Statutes. Acquisitions of Controlling Interest – Nevada Revised Statutes sections 78.378 to 78.379-3 provide state regulation over the acquisition of a “controlling interest” in certain Nevada corporations unless the articles of incorporation or bylaws of the corporation provide that the provisions of these sections do not apply. These provisions create a number of restrictions on the ability of a person or entity to acquire control of a Nevada company by setting down certain rules of conduct and voting restrictions in any acquisition attempt, among other things. Our Articles of Incorporation and our Bylaws do not state that these provisions do not apply. Combinations with Interested Stockholders – Nevada Revised Statutes sections 78.411 through 78.444 provide that a Nevada corporation with 200 or more stockholders of record generally may not engage in certain business combinations and transactions with an “interested stockholder” (in general, the beneficial owner of 10% or more of the corporation’s voting power) or the interested stockholder’s affiliates or associates during the two-year period after the stockholder first became an interested stockholder, nor generally even after such initial two-year period (until expiration of four years after becoming an interested stockholder), unless the business combination or transaction meets all of the requirements of the corporation’s articles of incorporation and, generally, is approved by the board of directors and also by a certain percentage of disinterested stockholders, in accordance with the specified statutory requirements. A corporation may elect not to be governed by these provisions only by expressly opting out in its original articles of incorporation or in an amendment approved by the majority vote of disinterested stockholders. Our Articles of Incorporation do not expressly opt out of these provisions. Other – In addition, Nevada Revised Statutes section 78.139 also provides that directors may resist a change or potential change in control of the corporation if the board of directors determines that the change or potential change is opposed to or not in the best interest of the corporation upon consideration of certain relevant facts, circumstances, contingencies or constituencies.

 

* * * * *

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]